MedPath

Effect of Hypochlorite Sodium 0.005% in treatment of Acne

Phase 2
Recruiting
Conditions
Acne Vulgaris.
Acne vulgaris
L70.0
Registration Number
IRCT20200701047976N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Patients with mild to moderate Acne Vulgaris diagnosed by dermatologist

Exclusion Criteria

Patients with symptoms such as secondary Acne caused by lactation
Dermatology condition in addition to Acne
Patients who had taken drugs such as Isotretinoin or systemic/topical antibiotics within the last two months
Allergy to Hypochlorite Sodium

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of Acne remission on the basis of changes in the number of Papules and Pustules. Timepoint: Initiation of study(before starting the treatment), 14 days and 28 days after starting the treatment. Method of measurement: Counting the number of Papules and Pustules.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath